While our ribosome profiling has identified a subset of cellular proteins regulated by BCMA signaling, we have identified ATMIN as a new target of BCMA that is regulated in a translation-specific manner and is important for MM viability. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.